Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azfar G Zaman

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|December 6, 2003
Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarctionAzfar G Zaman
Heart (British Cardiac Society)|November 5, 2020
Pharmacology before, during and after percutaneous coronary interventionAzfar G Zaman, Qaiser Aleem
Asiaintervention|September 30, 2024
Less is more: a new "thin-king" for DES?Azfar G Zaman, Abhishek Kumar
American Heart Journal|August 9, 2005
Reply to Ogimoto, angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy (Am Heart J 2005;149:e19.)Azfar G Zaman, Mark T Kearney
Clinical Medicine (London, England)|September 22, 2007
Antiplatelet therapy in acute coronary syndromesArun Natarajan, Ahmar Tarique, Azfar G Zaman
Diabetes & Vascular Disease Research|June 10, 2008
Platelet hyperactivity in type 2 diabetes: role of antiplatelet agentsArun Natarajan, Azfar G Zaman, Sally M Marshall
Coronary Artery Disease|September 11, 2012
Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studiesVijayalakshmi Kunadian, Andrew Pugh, Azfar G Zaman, et al.
Cardiovascular Therapeutics|January 17, 2014
Antiplatelet therapy in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a retrospective observational study of prasugrel and clopidogrelAaron Koshy, Karthik Balasubramaniam, Awsan Noman, et al.
Nature Clinical Practice. Cardiovascular Medicine|November 24, 2006
Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulationGérard Helft, Martine Gilard, Claude Le Feuvre, et al.
Cardiovascular Therapeutics|October 16, 2010
Unfractionated heparin during elective PCI: fixed dose or weight adjusted?Ananth Kidambi, Gnanamoorthy Mayurathan, Girish Viswanathan, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|December 6, 2003
Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarctionAzfar G Zaman
Heart (British Cardiac Society)|November 5, 2020
Pharmacology before, during and after percutaneous coronary interventionAzfar G Zaman, Qaiser Aleem
Asiaintervention|September 30, 2024
Less is more: a new "thin-king" for DES?Azfar G Zaman, Abhishek Kumar
American Heart Journal|August 9, 2005
Reply to Ogimoto, angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy (Am Heart J 2005;149:e19.)Azfar G Zaman, Mark T Kearney
Clinical Medicine (London, England)|September 22, 2007
Antiplatelet therapy in acute coronary syndromesArun Natarajan, Ahmar Tarique, Azfar G Zaman
Diabetes & Vascular Disease Research|June 10, 2008
Platelet hyperactivity in type 2 diabetes: role of antiplatelet agentsArun Natarajan, Azfar G Zaman, Sally M Marshall
Coronary Artery Disease|September 11, 2012
Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studiesVijayalakshmi Kunadian, Andrew Pugh, Azfar G Zaman, et al.
Cardiovascular Therapeutics|January 17, 2014
Antiplatelet therapy in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a retrospective observational study of prasugrel and clopidogrelAaron Koshy, Karthik Balasubramaniam, Awsan Noman, et al.
Nature Clinical Practice. Cardiovascular Medicine|November 24, 2006
Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulationGérard Helft, Martine Gilard, Claude Le Feuvre, et al.
Cardiovascular Therapeutics|October 16, 2010
Unfractionated heparin during elective PCI: fixed dose or weight adjusted?Ananth Kidambi, Gnanamoorthy Mayurathan, Girish Viswanathan, et al.
Pageof 5